Prenatal phthalate exposure and 8-isoprostane among Mexican-American children with high prevalence of obesity.

scientific article published on 29 December 2016

Prenatal phthalate exposure and 8-isoprostane among Mexican-American children with high prevalence of obesity. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1017/S2040174416000763
P932PMC publication ID5332297
P698PubMed publication ID28031075

P50authorKaren HuenQ56840169
P2093author name stringA Bradman
B Eskenazi
K Harley
K Parra
X Ye
B Nguyen
N Holland
V Tran
A M Calafat
G Tindula
K Kogut
P2860cites workEpidemiologic evaluation of measurement data in the presence of detection limitsQ24810926
Random-effects models for longitudinal dataQ28279619
Variability of urinary phthalate metabolite and bisphenol A concentrations before and during pregnancyQ28384139
Phthalate exposure and children's healthQ28387495
What is in our environment that effects puberty?Q28390102
Maternal phthalate exposure during pregnancy is associated with DNA methylation of LINE-1 and Alu repetitive elements in Mexican-American childrenQ28394822
Increased oxidative stress in obesity and its impact on metabolic syndromeQ29012150
Prevalence of childhood and adult obesity in the United States, 2011-2012Q29547370
Association of urinary phthalate metabolite concentrations with body mass index and waist circumference: a cross-sectional study of NHANES data, 1999-2002.Q30482472
Recent data on pubertal milestones in United States children: the secular trend toward earlier developmentQ31032046
The isoprostanes--25 years laterQ33601352
Intra-person variation of urinary biomarkers of oxidative stress and inflammationQ33866985
Variability in urinary phthalate metabolite levels across pregnancy and sensitive windows of exposure for the risk of preterm birthQ33922822
Vitamin C treatment reduces elevated C-reactive proteinQ34014359
Age and sex-specific relationships between phthalate exposures and obesity in Chinese children at pubertyQ34046867
Isoprostanes: markers and mediators of oxidative stressQ34372985
Obesity: a disease or a biological adaptation?Q34741872
PPAR-mediated activity of phthalates: A link to the obesity epidemic?Q34980414
Urinary phthalate metabolites in relation to biomarkers of inflammation and oxidative stress: NHANES 1999-2006.Q35033943
Prenatal and postnatal exposure to phthalate esters and asthma: a 9-year follow-up study of a taiwanese birth cohortQ35390530
Gender-specific association of oxidative stress and inflammation with cardiovascular risk factors in Arab population.Q35416137
Associations between Maternal Biomarkers of Phthalate Exposure and Inflammation Using Repeated Measurements across PregnancyQ35758784
Reactive oxygen species, vascular oxidative stress, and redox signaling in hypertension: what is the clinical significance?Q35840821
Quantification of isoprostanes as indices of oxidant stress and the risk of atherosclerosis in humansQ35980355
Prenatal Phthalate Exposure and Childhood Growth and Blood Pressure: Evidence from the Spanish INMA-Sabadell Birth Cohort StudyQ36112061
Exposure to Endocrine-Disrupting Chemicals during Pregnancy and Weight at 7 Years of Age: A Multi-pollutant ApproachQ36112088
Characteristics of reactive oxygen metabolites in serum of early teenagers in JapanQ36219898
Characterization of phthalate exposure among pregnant women assessed by repeat air and urine samplesQ36535139
Race/ethnicity-specific associations of urinary phthalates with childhood body mass in a nationally representative sampleQ36751009
Oxidative stress and cardiovascular risk in overweight children in an exercise intervention programQ36753135
Insights into oxidative stress: the isoprostanesQ36754565
Prenatal Phthalate Exposures and Body Mass Index Among 4- to 7-Year-old Children: A Pooled AnalysisQ36767823
Prenatal Exposure to Phthalates and Childhood Body Size in an Urban CohortQ36793434
Prenatal Phthalate Exposures and Childhood Fat Mass in a New York City CohortQ36793472
Associations of urinary phthalates with body mass index, waist circumference and serum lipids among females: National Health and Nutrition Examination Survey 1999-2004.Q37130099
The relationship of oxidative stress, adiposity and metabolic risk factors in healthy Black and White American youth.Q37179311
F(2)-isoprostanes as novel biomarkers for type 2 diabetes: a review.Q37246788
Systemic oxidative stress is increased to a greater degree in young, obese women following consumption of a high fat mealQ37390242
Urinary phthalate metabolite concentrations among pregnant women in Northern Puerto Rico: distribution, temporal variability, and predictorsQ37418653
Urinary Phthalate Metabolites and Biomarkers of Oxidative Stress in a Mexican-American Cohort: Variability in Early and Late PregnancyQ37518424
Mediation of the Relationship between Maternal Phthalate Exposure and Preterm Birth by Oxidative Stress with Repeated Measurements across Pregnancy.Q37674913
Environmental phthalate exposure and preterm birthQ37733477
Oxidative stress as pathogenesis of cardiovascular risk associated with metabolic syndromeQ37815201
Do phthalates act as obesogens in humans? A systematic review of the epidemiological literatureQ38177864
In utero and childhood DDT, DDE, PBDE and PCBs exposure and sex hormones in adolescent boys: The CHAMACOS studyQ38791866
Community level exposure to chemicals and oxidative stress in adult populationQ39864563
Urinary F2-isoprostanes in young healthy children at risk for type 1 diabetes mellitusQ40564040
Monophthalates promote IL-6 and IL-8 production in the human epithelial cell line A549.Q40573230
The isoprostanes: unique bioactive products of lipid peroxidationQ40901096
Increased plasma isoprostane is associated with visceral fat, high molecular weight adiponectin, and metabolic complications in obese childrenQ43156849
Role of fat oxidation in the long-term stabilization of body weight in obese womenQ43888112
Factors associated with oxidative stress in human populationsQ44079647
A survey of phthalates and parabens in personal care products from the United States and its implications for human exposureQ44100283
Oxidative stress in childhood obesityQ45067025
Analysis of biomarkers in a Czech population exposed to heavy air pollution. Part II: chromosomal aberrations and oxidative stressQ45396087
Urinary F2-isoprostanes are not associated with increased risk of type 2 diabetesQ46750273
Quantification of 22 phthalate metabolites in human urineQ46904037
Energy expenditure, fat oxidation, and body weight regulation: a study of metabolic adaptation to long-term weight changeQ47244308
Changes in Energy Expenditure Resulting from Altered Body WeightQ47357419
Age and sex differences in childhood and adulthood obesity association with phthalates: analyses of NHANES 2007-2010.Q51152093
Childhood BMI trajectories and the risk of developing young adult-onset diabetes.Q51942977
Plasma F2-isoprostanes are elevated in newborns and inversely correlated to gestational ageQ61756899
ObesityQ73552621
Secondary sexual characteristics in boys: estimates from the national health and nutrition examination survey III, 1988-1994Q74445673
Metabolism of 8-iso-prostaglandin F2alphaQ74724108
Association between Oxidative Stress and Masked Hypertension in a Multi-Ethnic Population of Obese Children and AdolescentsQ82447590
Oxidative stress and obesity: the chicken or the egg?Q88150404
P433issue2
P921main subject8-epi-prostaglandin F2alphaQ27116117
P304page(s)196-205
P577publication date2016-12-29
P1433published inJournal of Developmental Origins of Health and DiseaseQ15817934
P1476titlePrenatal phthalate exposure and 8-isoprostane among Mexican-American children with high prevalence of obesity
P478volume8